Form 144 - Report of proposed sale of securities:
SEC Accession No. 0002004379-24-000001
Filing Date
2024-10-01
Accepted
2024-10-01 17:12:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2829
  Complete submission text file 0002004379-24-000001.txt   4351
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Subject) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41562 | Film No.: 241344317
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NEWAMSTERDAM PHARMA COMPANY N.V. GOOIMEER 2-35 NAARDEN P7 1411 DC
Business Address
Kooij Louise Frederika (Reporting) CIK: 0002004379 (see all company filings)

Type: 144